Gunnar Sæther • 1972 • Trondheim • 6 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
B BIO PHARMA NORWAY AS	Managing Director/CEO	1,871,571	1,217,738	25 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
F FORTUNA EUROPE AS	Board Member	223,918	-240,713	25 % indirectly
C CECILIE LØVØS VEG 2 AS	Chairman	-	1,859,780	25 % indirectly
B BIO PHARMA NORWAY AS	Board Member	1,871,571	1,217,738	25 % indirectly
G GUTS HOLDING AS	Chairman	-	-1,474,581	25 % directly
N NORDIC PRINT AS	Chairman	14,017,524	2,806,882	25 % indirectly

Last update: Apr 13, 2023

Related industries2

Direct relationships5

TS
Terje Sæther1975
CECILIE LØVØS VEG 2 AS, BIO PHARMA NORWAY AS, GUTS HOLDING AS, NORDIC PRINT AS
SN
Siri Nielsen Sæther1968
CECILIE LØVØS VEG 2 AS, BIO PHARMA NORWAY AS, GUTS HOLDING AS
OL
Odd-Arne Landevåg1956
FORTUNA EUROPE AS
TB
Tom Benestad1971
BIO PHARMA NORWAY AS
IL
Ivar Larsen Fjeldberg1953
FORTUNA EUROPE AS

Shares owned by Gunnar Sæther

Name	Share class	Total operating income	Total equity	Share
G GUTS HOLDING AS	Ordinære aksjer	0	-1,474,581	25 % directly
F FORTUNA EUROPE AS		223,918	-240,713	25 % indirectly
C CECILIE LØVØS VEG 2 AS		0	1,859,780	25 % indirectly
B BIO PHARMA NORWAY AS		1,871,571	1,217,738	25 % indirectly
N NORDIC PRINT AS		14,017,524	2,806,882	25 % indirectly
M MEDICIAL AS		506,495	-420,691	3.13 % indirectly
B BLOCKCHAIN TECHNOLOGY AS		0	1,589,310	2.78 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025